Mr. Kroll has over twenty years of experience in the medical device industry. He has senior management experience, has conducted animal and pre-clinical human studies, and developed new surgical procedures for implanting medical devices. His experience includes both class II and III medical devices in the U.S., implantable and external. He was most recently VP of R&D at Ionix Medical, Inc. Prior to that, he was Director of Research at St. Croix Medical, now Envoy Medical. Previously he was with Empi (now DJO) and AngeMed (Angeion). Mr. Kroll holds over 50 issued U.S. patents and a B.S. & M.S. from the University of Minnesota. Mr. Kroll serves on the board of Galvani Ltd.
Mr. Hickey is a private investor and most recently the Chairman of Vital Images, Inc. (VTAL) which was sold to Toshiba Medical Systems in June of 2011. Mr. Hickey has served as President and Chief Executive Officer and Director of Myocor, Inc., a clinical-stage medical device company focused on cardiac surgery; President, Chief Executive Officer and a Director of Pulmonetic Systems, Inc. a manufacturer of portable respiratory care devices; President, CEO and Director of Angeion (ANGN), a manufacturer of implantable cardiac devices and President, CEO and Director of Aequitron Medical (AQTN), a manufacturer of pulmonary and adaptive mobility equipment. Previously Mr. Hickey spent fifteen years with American Hospital Supply Corporation/Baxter Healthcare, serving as President of two different divisions during his last six years. Mr. Hickey has also served as a director of a number of other public and private companies and associations. He is a 1975 graduate of the University of Illinois with a B.S. in Marketing and resides in the Minneapolis, MN area.
Dr. Kroll is currently the Chairman of Newcardio, Incorporated. Dr. Kroll formerly served as the Senior Vice President and Chief Technology Officer for the Cardiac Rhythm Management division of St. Jude Medical Inc. Dr. Kroll is the named inventor on over 300 U.S. patents as well as numerous international patents. He serves as an Adjunct Professor of Biomedical Engineering at both California Polytechnic University-San Luis Obispo, California, and at the University of Minnesota. Dr. Kroll is also a director of Haemonetics Corporation and Taser International, Inc.
Dr. Sembrowich is currently Chairman of Miromatrix Medical, an early stage regenerative medicine company. In 1999, he co-founded Travanti Pharma, Inc., an innovative drug delivery business, and served as Chairman and CEO from 1999-2007, and Director until the sale of the Company in 2010. From 1995-1999, he was President of Aviex Inc., an investment and management firm serving start-up and early stage medical companies. In 1990, Dr. Sembrowich co-founded Diametrics Medical, Inc. (DMED: Nasdaq), a manufacturer of point-of-care blood gas and electrolyte systems, where he served as CEO until 1993 and as Co-Chairman of the Board until 1996. He was a co-founder of Arden Medical Systems, Inc., a manufacturer of Dr.office chemistry systems and served as VP of Scientific Affairs and Director from 1983-88. Johnson and Johnson purchased Arden in 1987. From 1994-2003 he was a Director of St. Jude Medical (STJ: NYSE), a global cardiovascular device company. He has served on the boards of directors of Integ, eMed, Opticon Medical Inc., CuraMed Systems, Inc., EMVascular Inc. and Minnesota Project Innovation. He has also served as a reviewer for the Small Business Innovative Research program sponsored by the National Institutes of Health (N.I.H.). Dr. Sembrowich received a Bachelor of Science degree from Boston University, Master of Science degree from Illinois State University, and a Ph.D. from Washington State University. He was the recipient of an N.I.H. post doctoral fellowship. He has patents and numerous publications in the fields of medical technology and applied physiology.